Validation of population pharmacokinetic models: a comparison of internal and external validation approaches for hydrochlorothiazide

References

• Beermann B, Groschinsky-Grind M. 1979. Pharmacokinetics of hydrochlorothiazide in patients with congestive heart failure. Br J Clin Pharmacol. 7(6):579–583.
   PubMed Web of Science ®Google Scholar
• Beermann B, Groschinsky-Grind M, Rosén A. 1976. Absorption, metabolism, and excretion of hydrochlorothiazide. Clin Pharmacol Ther. 19(5 Pt 1):531–537.
   PubMed Web of Science ®Google Scholar
• Brendel K, Dartois C, Comets E, Lemenuel-Diot A, Laveille C, Tranchand B, Girard P, Laffont CM, Mentré F. 2007. Are population pharmacokinetic and/or pharmacodynamic models adequately evaluated? A survey of the literature from 2002 to 2004. Clin Pharmacokinet. 46(3):221–234.
   PubMed Web of Science ®Google Scholar
• Chae JW, Baek IH, Seo JW, Jung SH, Back HM, Song BJ, Lee BY, Yun HY, Kang W, Kwon KI, et al. 2014. Development of a population pharmacokinetic model to describe olmesartan medoxomil/ hydrochlorothiazide (20/12.5 mg) FDC tablet in male healthy South Korean subjects . Int J Clin Pharmacol Ther. 52(8):676–683.
   PubMed Web of Science ®Google Scholar
• Comets E, Brendel K, Mentré F. 2008. Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R. Comput Methods Programs Biomed. 90(2):154–166.
   PubMed Web of Science ®Google Scholar
• Commander SJ, Wu H, Boakye-Agyeman F, Melloni C, Hornik CD, Zimmerman K, Al-Uzri A, Mendley SR, Harper B, Cohen-Wolkowiez M, et al.; Best Pharmaceuticals for Children Act-Pediatric Trials Network Steering Committee. 2020. Pharmacokinetics of hydrochlorothiazide in children: a potential surrogate for renal secretion maturation. J Clin Pharmacol. 61(3):368–377.
   PubMed Web of Science ®Google Scholar
• Devijver PA. 1982. Pattern recognition: a statistical approach. London: Prentice-Hall.
   Google Scholar
• FDA 2020a. FDA approved drug products: Hydrochlorothiazide oral tablets; [accessed 2021 Nov 10]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/040735s004,040770s003lbl.pdf
   Google Scholar
• FDA 2020b. FDA approved drug products: Microzide capsules. [accessed 2021 Nov 10]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020504s018lbl.pdf
   Google Scholar
• Geisser S. 1993. Predictive inference. New York: Chapman and Hall.
   Google Scholar
• Haas M. 1994. The Na-K-Cl cotransporters. Am J Physiol. 267(4 Pt 1):C869–885.
   PubMedGoogle Scholar
• Han YF, Fan XH, Wang XJ, Sun K, Xue H, Li WJ, Wang YB, Chen JZ, Zhen YS, Zhang WL, et al. 2011. Association of intergenic polymorphism of organic anion transporter 1 and 3 genes with hypertension and blood pressure response to hydrochlorothiazide. Am J Hypertens. 24(3):340–346.
   PubMed Web of Science ®Google Scholar
• Hasannejad H, Takeda M, Taki K, Shin HJ, Babu E, Jutabha P, Khamdang S, Aleboyeh M, Onozato ML, Tojo A, et al. 2004. Interactions of human organic anion transporters with diuretics. J Pharmacol Exp Ther. 308(3):1021–1029.
   PubMed Web of Science ®Google Scholar
• Hedaya MA, Helmy SA. 2015. Modeling of the pharmacokinetic/pharmacodynamic interaction between irbesartan and hydrochlorothiazide in normotensive subjects. Biopharm Drug Dispos. 36(4):216–231.
   PubMed Web of Science ®Google Scholar
• Hens B, Bermejo M, Tsume Y, Gonzalez-Alvarez I, Ruan H, Matsui K, Amidon GE, Cavanagh KL, Kuminek G, Benninghoff G, et al. 2018. Evaluation and optimized selection of supersaturating drug delivery systems of posaconazole (BCS class 2b) in the gastrointestinal simulator (GIS): an in vitro-in silico-in vivo approach. Eur J Pharm Sci. 115:258–269.
   PubMed Web of Science ®Google Scholar
• Herman L, Bashir K. 2020. Hydrochlorothaizide. Treasure Island (FL): StatPearls Publishing.
   Google Scholar
• DrugBank 2020. Hydrochlorothiazide. [Updated 23 April 2020, Last accessed 10 Oct 2020]. https://www.drugbank.ca/drugs/DB00999
   Google Scholar
• Karatza E, Karalis V. 2020. Modelling gastric emptying: a pharmacokinetic model simultaneously describing distribution of losartan and its active metabolite EXP-3174. Basic Clin Pharmacol Toxicol. 126(3):193–202.
   PubMed Web of Science ®Google Scholar
• Karlsson M, Savic RM. 2007. Diagnosing model diagnostics. Clin Pharmacol Ther. 82(1):17–20.
   PubMed Web of Science ®Google Scholar
• Kimko HHC, Peck CC. 2010. Clinical trial simulation and quantitative pharmacology: applications and trends. New York (NY): Springer Science and Business Media.
   Google Scholar
• Koch G, Krzyzanski W, Pérez-Ruixo JJ, Schropp J. 2014. Modeling of delays in PKPD: classical approaches and a tutorial for delay differential equations. J Pharmacokinet Pharmacodyn. 41(4):291–318.
   PubMed Web of Science ®Google Scholar
• Kohavi R. 1995. A study of cross-validation and bootstrap for accuracy estimation and model selection. In: Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence. Morgan Kaufmann, San Mateo, p. 1137–1143.
   Google Scholar
• Mentre F, Escolano S. 2006. Prediction discrepancies for the evaluation of nonlinear mixed-effects models. J Pharmacokinet Pharmacodyn. 33(3):345–367.
   PubMed Web of Science ®Google Scholar
• Meyer MC, Melikian AP, Whyatt PL, Slywka GW. 1975. Hydrochlorothiazide bioavailability: an evaluation of thirteen products. Curr Ther Res Clin Exp. 17(6):570–577.
   PubMed Web of Science ®Google Scholar
• Mylan Pharmaceuticals 2020. Inc. Hydrochlorothiazide label. US Food & Drug Administration web site. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/040735s004,040770s003lbl.pdf. Revised May 2011. (Last accessed October 10, 2020)
   Google Scholar
• O’Neil MJ. 2001. The Merck Index - an encyclopedia of chemicals, drugs, and biologicals, 13th ed. Whitehouse Station (NJ): Merck & Co., Inc
   Google Scholar
• Panneer SM, Natrajan R, Selvaraj S, Rajendran NN. 2010. A novel drug–drug solid dispersion of hydrochlorothiazide losartan potassium. Int J Pharma Bio Sci. 1(4):68–80.
   Google Scholar
• Roecker EB. 1991. Prediction error and its estimation for subset selected models. Technometrics. 33(4):459–431.
   Web of Science ®Google Scholar
• Salvetti A, Ghiadoni L. 2006. Thiazide diuretics in the treatment of hypertension: an update. J Am Soc Nephrol. 17(4 Suppl 2):S25–S29.
   PubMed Web of Science ®Google Scholar
• Seely JF, Dirks JH. 1977. Site of action of diuretic drugs. Kidney Int. 11(1):1–8.
   PubMed Web of Science ®Google Scholar
• Sheiner LB, Beal SL. 1981. Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm. 9(4):503–512.
   PubMedGoogle Scholar
• Sherwin CMT, Kiang TKL, Spigarelli MG, Ensom MHH. 2012. Fundamentals of population pharmacokinetic modelling: validation methods. Clin Pharmacokinet. 51(9):573–590.
   PubMed Web of Science ®Google Scholar
• Sun H, Fadiran EO, Jones CD, Lesko L, Huang SM, Higgins K, Hu C, Machado S, Maldonado S, Williams R, et al. 1999. Population pharmacokinetics. A regulatory perspective. Clin Pharmacokinet. 37(1):41–58.
   PubMed Web of Science ®Google Scholar
• Tsume Y, Mudie DM, Langguth P, Amidon GE, Amidon GL. 2014. The biopharmaceutics classification system: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC. Eur J Pharm Sci. 57:152–163.
   PubMed Web of Science ®Google Scholar
• Tsume Y, Takeuchi S, Matsui K, Amidon GE, Amidon GL. 2015. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib. Eur J Pharm Sci. 76:203–212.
   PubMed Web of Science ®Google Scholar
• US FDA 2020. Guidance for industry: population pharmacokinetics model [online]. Available from URL: https://www.fda.gov/regulatory-information/search-fda-guidance/documents/population-pharmacokinetics. (Last accessed October 10,
   Google Scholar
• Van Wart SA, Shoaf SE, Mallikaarjun S, Mager DE. 2013. Population-based meta-analysis of hydrochlorothiazide pharmacokinetics. Biopharm Drug Dispos. 34(9):527–539.
   PubMed Web of Science ®Google Scholar
• Vertzoni M, Augustijns P, Grimm M, Koziolek M, Lemmens G, Parrott N, Pentafragka C, Reppas C, Rubbens J, Van Den Αbeele J, et al. 2019. Impact of regional differences along the gastrointestinal tract of healthy adults on oral drug absorption: an UNGAP review. Eur J Pharm Sci. 134:153–175.
   PubMed Web of Science ®Google Scholar
• Wei Y, Sun YY, Wang KS, Sun DL, Zheng MY. 2011. Pharmacokinetics of the combined preparation of lisinopril and hydrochlorothiazide on Chinese healthy volunteers. Yao Xue Xue Bao. 46(8):955–961.
   PubMedGoogle Scholar
• Welling PG. 1986. Pharmacokinetics of the thiazide diuretics. Biopharm Drug Dispos. 7(6):501–535.
   PubMed Web of Science ®Google Scholar
• Zanchetti A, Parati G, Malacco E. 2006. Zofenopril plus hydrochlorothiazide: combination therapy for the treatment of mild to moderate hypertension. Drugs. 66(8):1107–1115.
   PubMed Web of Science ®Google Scholar